Literature DB >> 18804762

Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT).

Aramesh Saremi1, Robert J Anderson, Ping Luo, Thomas E Moritz, Dawn C Schwenke, Mathew Allison, Peter D Reaven.   

Abstract

AIMS: The aim of the present study was to investigate the association of high-sensitivity C-reactive protein (CRP), interleukin-6 (IL-6) and lipoprotein-associated phospholipase A2 (Lp-PLA2) with the extent of calcified coronary atherosclerosis in patients with type 2 diabetes mellitus (T2DM). MATERIALS AND
RESULTS: This is a cross-sectional study of 306 subjects aged 40years or older who were enrolled into the veterans affairs diabetes trial (VADT). Calcified coronary atherosclerosis was assessed using electron beam computed tomography scored by the Agatston method. Clinical parameters, traditional cardiovascular risk factors and plasma levels of CRP, IL-6 and Lp-PLA2 were measured at the time of the scan. Coronary artery calcium (CAC) scores increased stepwise across increasing categories of IL-6, but did not change across increasing categories of CRP and Lp-PLA2. After adjustment for traditional cardiovascular risk factors, IL-6 was significantly associated with CAC scores (p=0.05). The association between IL-6 and CAC was largely in those with lower (below the median) abdominal artery calcium (AAC) levels (p=0.04).
CONCLUSIONS: Despite a generally higher level of systemic inflammation in T2DM, the inflammatory marker IL-6 remained significantly associated with CAC score, particularly in those subjects with lower AAC scores.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18804762      PMCID: PMC2688903          DOI: 10.1016/j.atherosclerosis.2008.07.031

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  29 in total

Review 1.  Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

Authors:  Paul M Ridker
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

2.  Quantification of coronary artery calcium using ultrafast computed tomography.

Authors:  A S Agatston; W R Janowitz; F J Hildner; N R Zusmer; M Viamonte; R Detrano
Journal:  J Am Coll Cardiol       Date:  1990-03-15       Impact factor: 24.094

3.  Coronary artery calcification at electron beam computed tomography is increased in asymptomatic type 2 diabetics independent of traditional risk factors.

Authors:  Megan L Wolfe; Nayyar Iqbal; Warren Gefter; Emile R Mohler; Daniel J Rader; Muredach P Reilly
Journal:  J Cardiovasc Risk       Date:  2002-12

Review 4.  Banting lecture 1988. Role of insulin resistance in human disease.

Authors:  G M Reaven
Journal:  Diabetes       Date:  1988-12       Impact factor: 9.461

5.  Expression of interleukin-6 in the ventricles and coronary arteries of patients with myocardial infarction.

Authors:  K Kaneko; T Kanda; T Yokoyama; Y Nakazato; T Iwasaki; I Kobayashi; R Nagai
Journal:  Res Commun Mol Pathol Pharmacol       Date:  1997-07

6.  Lack of concordance between plasma markers of cardiovascular risk and intima-media thickness in patients with type 2 diabetes.

Authors:  N Moussavi; G Renier; A Roussin; J-C Mamputu; J Buithieu; O Serri
Journal:  Diabetes Obes Metab       Date:  2004-01       Impact factor: 6.577

7.  Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III).

Authors:  Paul Muntner; Jiang He; Jing Chen; Vivian Fonseca; Paul K Whelton
Journal:  Ann Epidemiol       Date:  2004-10       Impact factor: 3.797

8.  Patterns and risk factors for systemic calcified atherosclerosis.

Authors:  Matthew A Allison; Michael H Criqui; C Michael Wright
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-12-04       Impact factor: 8.311

9.  Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Christie M Ballantyne; Ron C Hoogeveen; Heejung Bang; Josef Coresh; Aaron R Folsom; Gerardo Heiss; A Richey Sharrett
Journal:  Circulation       Date:  2004-02-02       Impact factor: 29.690

10.  Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.

Authors:  Carlos Abraira; William Duckworth; Madeline McCarren; Nicholas Emanuele; Danielle Arca; Domenic Reda; William Henderson
Journal:  J Diabetes Complications       Date:  2003 Nov-Dec       Impact factor: 2.852

View more
  24 in total

1.  Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis.

Authors:  Tracey G Simon; Maria Esther Perez Trejo; Robyn McClelland; Ryan Bradley; Michael J Blaha; Irfan Zeb; Kathleen E Corey; Matthew J Budoff; Raymond T Chung
Journal:  Int J Cardiol       Date:  2018-05-15       Impact factor: 4.164

Review 2.  Glucose targets for preventing diabetic kidney disease and its progression.

Authors:  Marinella Ruospo; Valeria M Saglimbene; Suetonia C Palmer; Salvatore De Cosmo; Antonio Pacilli; Olga Lamacchia; Mauro Cignarelli; Paola Fioretto; Mariacristina Vecchio; Jonathan C Craig; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2017-06-08

3.  DPP-4 (CD26) inhibitor alogliptin inhibits atherosclerosis in diabetic apolipoprotein E-deficient mice.

Authors:  Nga N Ta; Corinne A Schuyler; Yanchun Li; Maria F Lopes-Virella; Yan Huang
Journal:  J Cardiovasc Pharmacol       Date:  2011-08       Impact factor: 3.105

4.  IL-6 and high glucose synergistically upregulate MMP-1 expression by U937 mononuclear phagocytes via ERK1/2 and JNK pathways and c-Jun.

Authors:  Yanchun Li; Devadoss J Samuvel; Kamala P Sundararaj; Maria F Lopes-Virella; Yan Huang
Journal:  J Cell Biochem       Date:  2010-05       Impact factor: 4.429

5.  Interleukin-6 and E-selectin in acute coronary syndromes and stable angina pectoris. A comparative study.

Authors:  N Sarrafzadegan; M Sadeghi; F Ghaffarpasand; A Alisaeidi; H Sanei; H Zakeri; T Rastegar; A Amiri; M Dehghankhalili
Journal:  Herz       Date:  2012-07-07       Impact factor: 1.443

6.  Periodontal microbiota and phospholipases: the Oral Infections and Vascular Disease Epidemiology Study (INVEST).

Authors:  Adrien Boillot; Ryan T Demmer; Ziad Mallat; Ralph L Sacco; David R Jacobs; Joelle Benessiano; Alain Tedgui; Tatjana Rundek; Panos N Papapanou; Moïse Desvarieux
Journal:  Atherosclerosis       Date:  2015-07-22       Impact factor: 5.162

7.  Expanded network of inflammatory markers of atherogenesis: where are we now?

Authors:  Seyed Hesameddin Abbasi; Mohammad Ali Boroumand
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

8.  Inflammation, a link between obesity and cardiovascular disease.

Authors:  Zhaoxia Wang; Tomohiro Nakayama
Journal:  Mediators Inflamm       Date:  2010-08-05       Impact factor: 4.711

9.  Systematic Review of the Association between Lipoprotein-Associated Phospholipase A2 and Atherosclerosis.

Authors:  Jing Liu; Yuling Hong; Yue Qi; Fan Zhao; Dong Zhao
Journal:  N Am J Med Sci (Boston)       Date:  2011-10

10.  The levels of tumor necrosis factor-alpha and interleukin-6 in patients with isolated coronary artery ectasia.

Authors:  Mustafa Aydin; Ishak Ozel Tekin; Sait Mesut Dogan; Nesligul Yildirim; Mehmet Arasli; Muhammet Rasit Sayin; Ziyaettin Aktop
Journal:  Mediators Inflamm       Date:  2009-06-17       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.